Results 21 to 30 of about 7,746 (204)
Evidence‐based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis [PDF]
, 2021 Recurrent vulvovaginal candidiasis (RVVC) is a subtype of vulvovaginal candidiasis, with debilitating effects on physical and emotional well-being affecting up to 10% of Australian women.
Evelin Tiralongo +9 more
core +1 more source
Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran [PDF]
International Journal of Fertility and Sterility, 2009 Background Vulvovaginal candidiasis is the most common fungal disease in sexually active women of which Candida albicans is the primary etiologic agent. Materials and methods This cross-sectional study was performed to determine the etiologic agents of
Seddigheh Esmaeilzadeh +2 more
doaj +1 more source
Generalidades de la candidiasis vulvovaginal [PDF]
, 2023 Vulvovaginal Candidiasis is a disease caused by Candida species, mainly Candida albicans, which can colonize the vaginal mycoflora of healthy women, without causing disease.
González Garro, Ángela +2 more
core +4 more sources
Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns
Folia Medica, 2016 Vulvovaginal candidiasis is the second most common cause of vaginitis worldwide (after bacterial candidiasis). Maternal vulvovaginal candidiasis is a major risk factor for Candida colonization and infection of the infant where prognosis depends on ...
Zisova Liliya G. +8 more
doaj +1 more source
Dapagliflozin-Induced Vulvovaginitis in an Atopic Patient with Type 2 Diabetes Mellitus
Endocrinology Research and Practice, 2018 Dapagliflozin, an oral anti-diabetic agent, is a recently discovered sodium-glucose co-transporter receptor-2 inhibitor, which improves glycemic control by facilitating the renal excretion of glucose.
Narin NASIROĞLU İMGA +2 more
doaj +1 more source
Zaporožskij Medicinskij Žurnal, 2017 Aim - to determine population levels of main microbiota and yeast-like fungi of the genus Candida in healthy women and in women with vulvovaginal candidiasis. Materials and methods. For 10 years we have been surveyed 270 women in reproductive age from
N. D. Yakovychuk +5 more
doaj +1 more source
Pathogens, 2023 Epidemiological data on women suffering from vulvovaginal candidiasis and its recurrence are outdated and vague. The aim of this study was to identify the prevalence of women diagnosed with vulvovaginal candidiasis, as well as the epidemiological profile
Encarnación Martínez-García +6 more
doaj +1 more source
Vulvovaginal candidiasis-related symptoms and conditions. [PDF]
, 2022 Vulvovaginal candidiasis-related symptoms and conditions.
Brendan R. Jackson (8575074) +2 more
core +1 more source
Immunopathogenesis of recurrent vulvovaginal candidiasis [PDF]
Clinical Microbiology Reviews, 1996 Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic ...
P L, Fidel, J D, Sobel
openaire +3 more sources
Recurrent urogenital candidiasis: diagnosis and treatment
Медицинский совет, 2015 Vulvovaginal candidiasis is the most common manifestation of urogenital candidiasis. The disease is widespread among women of reproductive age. The disease recurs in 5-10% of cases.
A. M. Savicheva, E. V. Shipitsyna
doaj +1 more source